Factors predicting survival following alloSCT in patients with therapy-related AML and MDS: a multicenter study

Baranwal, A; Chhetri, R; Yeung, DV; Clark, M; Shah, SYD; Litzow, MR; Hogan, WJ; Mangaonkar, A; Alkhateeb, HB; Singhal, D; Cibich, A; Bardy, P; Kok, CH; Hiwase, DK; Shah, MV

Shah, MV (通讯作者),Mayo Clin, Div Hematol, Rochester, MN 55905 USA.;Shah, MV (通讯作者),Mayo Clin, William J von Leibig Ctr Transplantat, Rochester, MN 55905 USA.;Hiwase, DK (通讯作者),Royal Adelaide Hosp, Cent Adelaide Local Hlth Network, Adelaide, SA, Australia.;Hiwase, DK (通讯作者),Univ Adelaide, Adelaide, SA, Australia.;Hiwase, DK (通讯作者),South Australian Hlth & Med Res Inst SAHMRI, Precis Med Theme, Adelaide, SA, Australia.

BONE MARROW TRANSPLANTATION, 2023; 58 (7): 769

Abstract

Therapy-related myeloid neoplasms (t-MN) are aggressive myeloid neoplasms. Factors predicting post-allogeneic stem cell transplant (alloSCT) survival ......

Full Text Link